NCT07125599Completed
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
The Association Between Clinical, Laboratory and Ultrasonographic Findings With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
Source: ClinicalTrials.gov · Last updated 27 Aug 2025
Brief summary (registry, in English)
pregnant women diagnosed with severe preeclampsia were subjected to • Full history taking including a detailed history of the hypertension state during the current pregnancy (onset, course, current medication, and whether the blood pressure is controlled or not).gravidity , parity mode of delivery any medical disorders, the presence of headache ,blurring of vision and epigastric pain. * Complete physical examination: general (including BMI \& blood pressure measurement) and obstetric examinations. * Routine obstetric ultrasound and Doppler indices Including umbilical artery Doppler (RI). * Laboratory investigations : 1\. Complete blood count (CBC). 2 albuminuria will be detected by dipstick kits . 3. Liver enzymes \& kidney function. 4.PT,PC,INR. * Pelvic-Abdominal ultrasound to assess the presence of ascites Ultrasound examination will be performed by a consultant obstetrician to detect free fluid in the peritoneal cavity, especially at hepato-renal pouch, sub-splenic area, or para-colic gutters. The presence of ascites will be further confirmed at the time of delivery. 3-All labours will be attended by an expert neonatologist and the following will be recorded: * APGAR score at (1 min). * The further need for neonatal intensive care unit (NICU) admission. * Perinatal death
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 284 (actual)
- First submitted
- 9 Aug 2025
- Start date
- 2 May 2020
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Cairo University
- NCT number
- NCT07125599
What you commit to
- Study type: Observational
- Participants enrolled: 284
- From 2 May 2020 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- known liver disease
- Maternal medical disorders rather than hypertension.
- Renal disorder.
- History of illicit drug use.
- Associated inflammatory disease or sepsis.
Other
- Rupture of membrane.
- Fetal congenital anomalies.
- The maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic )
Who the study is looking for
- Maternal age from 18 to 40 years.
- Gestational age (28\_38) weeks, confirmed by the first day of the last menstrual period or first trimesteric ultrasound
- All suffering of severe preeclampsia
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.